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Whole-body deep hypothermia (DH) could be a new therapeutic strategy for asphyxiated newborn. This retrospective study
describes howDHmodified the heart rate and arterial blood pressure if compared tomild hypothermia (MH). Fourteen in DH and
17 inMHwere cooled within the first six hours of life and for the following 72 hours. Hypothermia criteria were gestational age ≥ 36
weeks; birth weight ≥ 1800 g; clinical signs of moderate/severe hypoxic-ischemic encephalopathy. Rewarming was obtained in the
following 6–12 hours (0.5∘C/h) after cooling. Heart rates were the same between the two groups; there was statistically significant
difference at the beginning of hypothermia and during rewarming. Three babies in the DH group and 2 in the MH group showed
HR < 80 bpm and QTc > 520ms. Infant submitted to deep hypothermia had not bradycardia or Qtc elongation before cooling
and after rewarming. Blood pressure was significantly lower in DH compared to MH during the cooling, and peculiar was the
hypotension during rewarming in DH group. Conclusion. The deeper hypothermia is a safe and feasible, only if it is performed by
a well-trained team. DH should only be associated with a clinical trial and prospective randomized trials to validate its use.
1. Introduction
Hypoxic-ischemic encephalopathy (HIE) is a disease that
induces death and severe neurological damage in newborns
[1]. Hypothermia is now the first effective neuroprotective
intervention for newborns that are critically ill following an
asphyxial insult. Hypothermia showed a decrease in death or
disability at 18 months [2–5]. Parkins et al. firstly introduced
hypothermia as a neuroprotectivemethod, but the side effects
were higher, so the practice had been abandoned [6]. Meta-
analysis about eight largest RCTs had confirmed that cooling
reduced mortality without increasing handicap in survivors
[7]. Two meta-analyses have confirmed that hypothermia
was associated with a lower risk of death or moderate/severe
neurodevelopmental disorder in childhood, but with an
increased risk of arrhythmia and thrombocytopenia [8, 9].
Perlman suggested that deeper or more prolonged cooling
could be able to treat more severe neonatal asphyxia [2].
The early studies of deep hypothermia (20–27∘C) have found
some neurological benefits, but the side effects dramatically
increased below 32∘C and passed all potential clinical ben-
efits [10]. Shivering and cardiac arrhythmias were the most
pronounced of these side effects [11, 12]. Cardiac arrhythmias,
hypotension, hemoconcentration, sinus bradycardia, and
peripheral vasoconstriction are common adverse events in
neonatal hypothermia [13–15]. Safety and respiratory func-
tion during deep hypothermia (DH) in asphyxiated newborn
were previously reported [16, 17]. Retrospective analysis
of circulatory parameters is part of a prospective study
designed to investigate the safety of the topiramate [18, 19].
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The objective of this retrospective analysis was to investigate
how heart rate and systemic arterial pressure were modified
byDH (core temperature 30–33∘C). Results were compared to
a group of term infants with hypoxic-ischemic encephalopa-
thy (HIE) treated with milder levels of hypothermia (MH)
(core temperature 33-34∘C).
2. Methods
Asphyxiated newborns included in the analysis were those
treated with whole-body DH or MH within the first 6 hours
of life and if the two following criteria were fulfilled: (1)
gestational age ≥36 weeks and birth weight ≥1.800 g, with at
least one of the following: (a) Apgar score ≤5 at 10 minutes;
(b) endotracheal intubation or mask ventilation for more
than 10 minutes after birth; (c) acidosis (pH ≤ 7.0 and/or
basic excess ≥−16mmol/L in umbilical cord blood or arterial,
venous, or capillary blood) within 60 minutes from birth; (2)
moderate to severe encephalopathy consisting of altered state
of consciousness (irritability, lethargy, stupor, or coma) and
≥1 of the following signs: (a) hypotonia, (b) abnormal reflexes,
including oculomotor or pupillary abnormalities, (c) absent
or weak suctioning, and (d) clinical seizures [3, 10]. Between
November 2004 and May 2010, 78 asphyxiated newborns
with HIE were retrospectively compared: 37 patients were
treated with DH and 41 with MH. Four patients in each
group were excluded because they were cooled with ice
packs. Nineteen patients in DH and 20 patients in MH were
excluded because they received inotropic supply. Fourteen
patients in DH and 17 in MH were analyzed.
Patients were cooled by two different cooling blankets,
NIG 2 (IemmiMedical Srl.; Mantova, Italy) and Blanketrol III
(Hyper-Hypothermia System, Cincinnati Sub-Zero, Cincin-
nati, OH, USA). Monitoring was performed by a rectal and
esophageal probe. Skin temperature was monitored on the
abdominal wall with a skin probe by the radiant warmer
thermal sensor or a temperature-monitoring unit (Mon-a-
therm; Mallinckrodt Medical, St. Louis, MO, USA). The
target of the core temperaturewas 31∘Cand 33.5∘C forDHand
MH, respectively. Coolingwasmaintained between the stated
targets for 72 h, and rewarming to 36.5–37∘C was gradually
obtained over the following 6–12 h (0.5∘C/h).
Arterial blood gas, coagulation, and biochemistry were
daily checked and temperature corrected. Chest X rays
and echocardiography (Acuson Sequoia C512, Siemens, Ger-
many) were performed at the admission. The scans were
performed by 2 experienced operators. Respiratory rate,
heart rate (HR), blood pressure (BP), and oxygen satura-
tion were continuously monitored during hypothermia and
rewarming. BP was measured by using standard oscillo-
metric methods. Invasive blood pressure monitoring was
not performed routinely. Only oscillometric blood pressure
values were selected for analysis to reduce the bias. Standard
electrocardiogram was obtained when bradycardia (HR of
<80 bpm) or arrhythmia (extrasystoles, bundle branch block)
was observed. Hypotension, defined as mean arterial blood
pressure (MAP) <40mm Hg, was, firstly, treated with sin-
gle or repeated normal saline boluses (10–20mL/kg) and
subsequently by dopamine, while dobutamine was infused
when the reduction of myocardial contractility was found.
Dopamine or dobutamine was started at an initial dose
of 5 ug/kg/min and was increased by 5 ug/kg/min up to a
maximum dose of 15 ug/kg/min. Fluid intake was started at
60 to 70mL/kg and increased by 10 to 20mL/kg each day,
based on changes in bodyweight and serum electrolyte levels.
Clinical seizures were treated with phenobarbital (loading
dose, 20mg/kg; followed by 1.5–2.5mg/kg every 12 hours).
Oral topiramate was administered as neuroprotective drug
at starting time of hypothermia, once a day for 3 days
[18, 19]. Inhaled nitric oxide was started when PPHN was
echographically demonstrated.
Brain magnetic resonance imaging (MRI) was planned
within the first week of life. Brain lesions were classified as
isolated lesions of white matter, basal ganglia, and thalamus
with or without involvement of posterior limb of the internal
capsule, cortex, or various combinations of the earlier lesions
[20].
3. Statistical Analyses
Results were shown as mean ± SD or percentage. Statisti-
cal analyses were performed using Student’s 𝑡-test, Mann-
Whitney test, and ANOVA; categorical variables were ana-
lyzed using Fisher exact test or 𝜒2 analyses. A paired 𝑡-test
was used to determine the effect of a single treatment.𝑃 value
of ≤0.05 was considered significant.
4. Results
Newborns reported in three earlier study were included [17–
19]. Seventy-eight asphyxiated newbornswere retrospectively
compared from November 2004 to May 2010: 37 patients
were treated with DH, and 41 with MH. Four patients in
both groups were excluded because they were cooled with ice
packs. Nineteen patients in DH and 20 patients in MH were
excluded because they received inotropic supply. Fourteen
patients inDHand 17 inMHwere analyzed, and therewas not
a statistically significant difference between the two groups
(𝑃 = 0.855). Perinatal and basic characteristics of the infants
were not significantly different (Table 1). Core temperatures
were the same between the two groups at hypothermic
starting time. During treatment, the core temperature was,
respectively, maintained at 31∘C and 33.5∘C in DH and MH.
There was a statistical significant difference (𝑃 < 0.001)
from 6 to 72 hours between the two groups (Figure 1). At
starting cooling, mean HR was 110 bpm and 111 bpm during
DH and MH, whereas it was reduced at 97 bpm and 105 bpm
during DH and MH (Figure 2). Three babies in DH (20%)
and 2 in MH (11.7%) showed a sinus bradycardia (HR
< 80 bpm), with a significant increase in QTc (>520ms)
during hypothermia (𝑃 = 0.326). Newborns did not have
bradycardia before cooling and after rewarming. Heart rate
decreased significantly by a mean of 11 bpm in DH and nine
bpm inMH on cooling (Figure 2). Sinus bradycardia was not
associated with a decrease of mean arterial pressure (MAP),
and arrhythmia has not been reported. Mean systolic arterial
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Table 1: Basic characteristics of the group. (mean ± SD or n and %).
Group DH
n = 14/31 (45.1)
Group MH
n = 17/31 (54.9) P value 95% C.I.
Weight g (SD) 3296 (±659) 3292 (±608) 𝑃 = 0.982 −299.0–305.7
Gestational age weeks (SD) 39.6 (±1.7) 39.2 (±1.9) 𝑃 = 0.488 −0.737–1.222
Inborn 𝑛 (%) 5/14 (35.7) 7/17 (23.5) 𝑃 = 0.738 −0.482–0.726
Male 𝑛 (%) 6/14 (42.8) 12/17 (70.5) 𝑃 = 0.533 −0.754–0.200
Caucasian race 𝑛 (%) 11/14 (78.5) 13/17 (76.4) 𝑃 = 0.714 −0.315–0.357
Vaginal delivery 𝑛 (%) 6/14 (42.8) 10/17 (58.8) 𝑃 = 0.897 −0.606–0.406
Apgar 5󸀠 (SD) 4.8 (±2.0) 4.1 (±2.1) 𝑃 = 0.419 −0.334–1.607
Umbilical cord pH (SD) 6.881 (±0.1) 6.996 (±0.2) 𝑃 = 0.066 −0.397–0.079
Umbilical cord paCO2 (mmHg) (SD) 90.2 (±34.0) 68.3 (±32.4) 𝑃 = 0.080 −2.730–46.423
Umbilical cord BE (mmol/L) (SD) −17.0 (±4.1) −17.7 (±7.1) 𝑃 = 0.981 −2.592–7.207
Umbilical cord lactate (mmol/L) (SD) 12.1 (±6.3) 14.1 (±4.6) 𝑃 = 0.378 −6.694–2.632
Onset of hypothermia h (SD) 3.2 (±1.5) 3.3 (±1.2) 𝑃 = 0.957 −0.697–0.528
Length of hospitalization (days) (SD) 16.7 (±12.9) 13.1 (±7.2) 𝑃 = 0.270 −0.201–9.171
DH: deep hypothermia. MH: mild hypothermia. SD: standard deviation. BE: basic excess. h: hours.
pressure was 66mmHg and mean diastolic blood pressure
was 41mmHg, during DH. During MH, mean systolic blood
pressure was 72mmHg, and mean diastolic blood pressure
was 46mmHg (Figure 3). Blood pressure was significantly
lower in DH than MH, and DH group presented a greater
decrease inMAP during rewarming compared withMHwith
several statistical significance. Two newborns in MH and
one in DH died, and that occurred 72 hours after hypother-
mia. Length of hospitalisation was similar in both groups
(Table 1).
5. Discussion
Cardiovascular changes during cooling have a significant
incidence on systemic sequelae in infants with HIE. The
experimental data have shown that duringmild hypothermia,
left ventricular contractility and cardiac output decreased
[21–23].This is the first report that compares the cardiovascu-
lar function in treated asphyctic newborns with two different
degrees of hypothermia. This report has demonstrated how
the MAP changed during DH while HR remained the same
changing degrees of cooling. In both treatment groups,
target temperature was reached andmaintained. Cooling was
the same even using two different devices, and statistical
difference was significant during hypothermia (Figure 1).
Indeed, Hoedemaekers et al. showed that the use of different
blankets did not change the induction and maintenance of
cooling [24].
Thoresen and Whitelaw have documented how HR and
MAP changed in asphyxiated newborns during hypothermia
and rewarming. In fact, while the MAP increased, HR
decreased during the cooling, and the opposite occurred
during the rewarming [25]. Already three randomized con-
trolled trials have been reported as a decrease in HR was
reversible [3, 4, 13]. In the same way, it was already described
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Figure 1: Core temperature during DH and MH (mean; standard
deviation). The black and grey solid lines represent the core
temperature during DH and MH. The black asterisk (∗) represents
the statistical significance with 𝑃 < 0.05. The black diamond (⧫)
represents the statistical significance with 𝑃 < 0.001. Core tempera-
tures were the same between the two groups at starting hypothermic
time; then the mean core temperature was 31∘C and 33.5∘C in DH
and MH, respectively. DH and MH had an analogous trend during
cooling and rewarming.There was a statistical significant difference
(𝑃 < 0.001), from 6 to 72 hours, between the two trends during
cooling. There was statistical significance between prehypothermic
and hypothermic temperature and hypothermic and postrewarming
temperature (𝑃 < 0.001).
as neonates undergoing hypothermia were also exposed to
sinus bradycardia and hypotension [7, 12, 26]. Furthermore,
QTc elongation is a typical anomaly during hypothermia.
Gunn et al. reported that HR of infants submitted to head
cooling decreased and, at the same time, increased the QT
interval. After rewarming, HR and QT interval came back to
normal range [20, 27–30].
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Figure 2: Heart rate during DH and MH (mean; standard devia-
tion). The black dashed line represents the heart rate (HR) of new-
borns in deep hypothermia (DH). The grey dashed line represents
theHR of newborns inmild hypothermia (MH).The black diamond
(⧫) represents the statistical significance with 𝑃 < 0.001. HR was
very comparable between the two groups at starting hypothermic
time and during hypothermia. There was statistical significance
between prehypothermic and hypothermic HR and hypothermic
and postrewarming HR (𝑃 < 0.001).
In this report, HR rapidly decreased during cooling
induction and quickly increased during passive rewarming.
Sinus bradycardia has been observed in both groups, while
a significant increase in QTc developed only in 5 patients.
The depth of hypothermia did not appear to affect HR while
the induction of cooling and the gradual warming seemed to
affect it (Figure 3).
Studies on pressure data are contradictory, because some
have reported a pressure decrease, while others have docu-
mented an increase in blood pressure during hypothermia
[7, 25].
In this report, blood pressures inevitably fall after the
beginning of hypothermia in both groups and more in
that subjected on deep hypothermia (Figure 3). However, a
further decrease in blood pressure had been observed during
rewarming only in DH group, as described by Thoresen and
Whitelaw [25]. Although the rewarming rate was similar in
both groups (0.5∘C/h), we assumed that this rate was too
elevated for those patients undergoing a more deep cooling.
Therefore, based on previous studies, it is to suggest that there
may be some benefit to give volume at the time of rewarming
to “prime” the circulation [31].
Blood pressure significantly lower in the DH may be
explained with inhibition of endogenous catecholamines
activity following the further reduction on body temperature
below 33∘C. Indeed, Chernow et al. measured HR, MAP,
and plasma levels of catecholamines during progressive
hypothermia to 29∘C and then during rewarming to 37∘C
on baboon. HR, MAP, and plasma levels of epinephrine and
norepinephrine increased significantly when the temperature
dropped to 33∘C. A further reduction in temperature to
29∘C corresponded with a reduction in HR, MAP, and cate-
cholamine to prehypothermic levels. Therefore, sympathetic
nervous system immediately responds to hypothermia but
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Figure 3: Change in arterial pressure during DH and MH (mean;
standard deviation). The systolic (SAP), mean (MAP), and dias-
tolic arterial pressure (DAP) was represented with black and grey
dashed lines in patients during deep hypothermia (DH) and mild
hypothermia (MH), respectively. The black asterisk (∗) represents
the statistical significance with 𝑃 < 0.05.
may be “switched off” at threshold temperature of about 29∘C
[32].
We also speculated that hypotension was probably also
due to hypoxic multiorgan or multisystemic dysfunction
(MOD) [33]. It is necessary to remember that MOD as
renal, cardiovascular, pulmonary, or hepatic involvement is
frequent in postasphyxial infants and is, respectively, present
in 70%, 62%, 86%, and 85% of infants with HIE [33].
The adverse effects of deep cooling may be more severe
in asphyxiated newborns with multiorgan dysfunction, or
multiorgan dysfunction could be amplified by superimposed
cold-injury syndrome [34, 35]. In an experimental adult
dog model, deep hypothermia (15∘C) produced worse cere-
bral and cardiac outcomes [36], whereas controlled mild
hypothermia (34–36∘C) provided consistent neuroprotective
benefits [37]. The mechanisms of adverse effect of deep
hypothermia or “overcooling” on cerebral outcome are not
clear but might be related to myocardial dysfunction leading
to decrease in cardiac output, systemic hypotension, and
compromised cerebral perfusion [22, 36, 38, 39]. Deep
hypothermia used in this study did not seem to be as
profound as that used on the dogs by Dudgeon et al. [22], but
it could itself be responsible to hypotension.
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6. Conclusion
In conclusion, the present report confirms that patients under
DH are also subjected to cardiovascular dysfunction. Indeed,
DH patients are subject to an increased risk of hypoten-
sion both during and after hypothermia. Small sample size,
retrospective data collection, BP recording method, and
observational clinical markers of cardiovascular status limit
the power of our conclusions. However, deep hypothermia is
safe and feasible treatment only if performedby awell-trained
team [16, 17]. While moderate hypothermia can now be
considered a “standard care” in asphyxiated term infants, DH
should only be associated to a clinical trial. New prospective
randomized trials are needed to validate its use.
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